| Date | Title | Description |
| 30.08.2026 | AI Transforms Healthcare Billing: Arintra Secures $25 Million Investment | Arintra secured $25 million in Series B funding. Total capital reached $51 million. This empowers its AI platform for healthcare revenue assurance. The technology optimizes medical coding. It significantly slashes claim denials. It cuts adm... |
| 27.08.2026 | Arintra Raises $25 Million Series B As AI Revenue Platform Processes $5 Billion In Annual Claims | Arintra has raised $25 million in Series B funding to expand its AI-powered healthcare revenue assurance platform, bringing the company’s total funding since inception to $51 million.
Define Ventures led the round, with participation from P... |
| 26.08.2026 | Arintra Raises $25M in Series B Funding | Arintra, an Austin, Texas-based provider of an enterprise AI platform for healthcare revenue assurance, raised $25M in Series B financing.
The round was led by Define Ventures with participation from Peak XV Partners, Yale New Haven Health ... |
| 19.08.2026 | A fungus that can cause severe infections is spreading across US. Doctors explain risks | Getting your Trinity Audio player ready...
A drug-resistant fungus is spreading across the United States, with 3,437 clinical cases documented nationwide this year in 27 states, according to data from the Centers for Disease Control and Pre... |
| 06.08.2026 | Beyond AI Scribes: Why Ambient Clinical Intelligence Is Health IT’s Greatest Governance Test | Akhila Akula, Data Architect at Midland Health
Two years ago, ambient AI scribes were a mere curiosity. A handful of health systems ran the pilots. Conference demos drew crowds but not purchase orders. That phase is over.
Nearly two-thirds ... |
| 31.07.2026 | 32-year-old doctor works in the hospital where she was a teenage janitor: How she and her husband plan to tackle debt and build wealth | This story is part of CNBC Make It’s Millennial Money series, which examines how people earn, spend and save their money.
There are full-circle moments, and then there’s what Shay Taylor-Allen experienced in March. Upon completing her studi... |
| 28.07.2026 | Trump administration demands hospitals share emergency room records | Getting your Trinity Audio player ready...
By Amanda Seitz, Maia Rosenfeld, and Darius Tahir, KFF Health News
A tiny federal agency tasked with protecting the public from injuries caused by lawn mowers and coffeemakers is demanding that som... |
| 14.07.2026 | Rad AI Appoints Former Google Cloud and Coinbase Executive Leonard Law as Chief Product Officer | , the leader in AI-powered radiology workflow solutions, announced Leonard Law as Chief Product Officer. Law joins the company at a pivotal moment for the radiology reporting market, as health systems and radiology practices modernize decad... |
| 19.06.2026 | Man’s ear infection spread to his brain. His family claims it could’ve been caught before he died | Getting your Trinity Audio player ready...
A Connecticut man who went to an urgent health care facility with an earache died about three weeks later from infection of the middle ear that led to a bone infection and then a brain abscess, an ... |
| 15.06.2026 | Scottsdale Center for Plastic Surgery Welcomes Facial Plastic and Reconstructive Surgeon Dr. Donovan Lockwood | Led by Dr. Robert Cohen, Dr. Steven Sigalove, and Dr. Donovan Lockwood, the practice is dedicated to delivering exceptional outcomes through innovation, precision, and personalized care.
PARADISE VALLEY, Ariz., June 15, 2026 /PRNewswire-PRW... |
| 28.05.2026 | Triomics: $22 Million Raised To Scale AI Infrastructure For Oncology Workflows | Triomics, an oncology AI company helping cancer centers operationalize complex clinical information, announced it has raised $22 million in Series B financing led by Battery Ventures, with participation from existing investors Nexus Venture... |
| 25.08.2025 | Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer | SAN FRANCISCO and SUZHOU, China, Aug. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing and commercializing high-quality me... |
| 27.07.2025 | A doctor sees new hope for Alzheimer’s disease patients and families. He wants you to know why | Azizi said there is no cure for Alzheimer’s, but the disease can be “modified” with medications from two different companies.
The medications approved about two years ago are Lecanemab, also known as Leqembi and Kisunla, also known as Donan... |
| 23.07.2025 | Aidoc Secures $150 Million for CARE, its Healthcare Foundation Model, to Transform Clinical Decision-Making for 100 Million Patients | The Era of Clinical AI Has Arrived: Trusted by Leading Health
Aidoc, the leading clinical AI platform with the highest number of FDA-cleared solutions in its category, announced a $150 million financing round to accelerate the development o... |
| 26.06.2025 | Dr. Renier Brentjens Recognized by Two Prominent Cancer Research Organizations | Dr. Renier Brentjens gave invited talks at two national events this month.
Roswell Park cellular therapy pioneer invited to address Damon Runyon Foundation, New York Academy of Sciences
BUFFALO, N.Y., June 26, 2025 /PRNewswire-PRWeb/ -- Ren... |
| 18.02.2025 | The Hidden Dangers of Antibiotic Allergies and Early Exposure | In the world of medicine, labels can be a double-edged sword. They can guide treatment but also mislead. Recent studies highlight a pressing issue: the mismanagement of penicillin allergies and the risks of early-life antibiotic exposure. B... |
| 18.02.2025 | Unmasking Allergies: The Hidden Dangers of Mislabeling in Healthcare | In the world of medicine, labels can be a double-edged sword. They can guide treatment or mislead practitioners. Recent studies highlight a troubling trend: many patients, especially those undergoing hematopoietic stem cell transplants (HSC... |
| 18.02.2025 | The Hidden Dangers of Allergy Labels: A Call for Change in Patient Care | In the world of medicine, labels can be both a blessing and a curse. They provide essential information but can also mislead. Recent studies highlight a troubling trend: inaccurate allergy labels are jeopardizing the health of vulnerable pa... |
| 18.02.2025 | Breaking Barriers: New Insights into Allergy Treatments and Testing | In the world of allergies, new research is shining a light on two critical areas: peanut oral immunotherapy and the testing of penicillin allergies in hematopoietic stem cell transplant patients. These studies, presented at the 2025 AAAAI /... |
| 12.02.2025 | Hematopoietic Stem Cell Transplant Patients Rarely Tested for Penicillin Allergy | AAAAI
Inaccurate penicillin allergy labels limit access to preferred antibiotics
MILWAUKEE, Feb. 12, 2025 /PRNewswire-PRWeb/ -- Immunocompromised patients undergoing hematopoietic stem cell transplants (HSCTs) who have a reported penicillin... |
| 27.11.2024 | Development milestones to propel Medtechs to next step |
Following the approval from Health Canada, Aktiia has launched its cuffless bracelet in Canada, marking its first market outside Europe. The Health Canada-approved medical device represents a significant advancement in the measurement of b... |
| 26.11.2024 | The Future of Ventilation: STIMIT's Noninvasive Diaphragm Neurostimulation Device | In the world of critical care, innovation is a lifeline. STIMIT AG is at the forefront, enrolling patients in a groundbreaking clinical trial for its noninvasive diaphragm neurostimulation device. This technology aims to transform how we ap... |
| 20.11.2024 | STIMIT is Enrolling Patients in Clinical Trial of Noninvasive Diaphragm Neurostimulation Device – Pioneering a Transformation in Ventilation and Critical Care | BIEL, Switzerland–(BUSINESS WIRE)–November 20, 2024–
STIMIT AG announced today it is enrolling patients in its FDA Investigational Device Exemption (IDE) clinical trial, “STIMIT ACTIVATOR 1 PIVOTAL STUDY,” with world renowned clinical cente... |
| 21.08.2024 | Clarium's $10.5M Boost: Revolutionizing Hospital Supply Chains with AI | In the ever-evolving landscape of healthcare, efficiency is the golden key. Clarium, Inc. has just unlocked a new door with its recent $10.5 million funding round. This investment, led by General Catalyst and supported by notable players li... |
| 20.08.2024 | Clarium Secures $10.5M for AI-Powered Hospital Supply Chain | What You Should Know:
– Clarium, Inc., a healthcare technology innovator focused on transforming hospital supply chain operations, has secured a $10.5M in strategic financing round led by General Catalyst, with participation from Kaiser Per... |
| 14.04.2023 | Hyatus Stays Launches Monthly Furnished Apartments in Downtown New Haven | Hyatus is now offering monthly Academic Housing in New Haven for students, travelling nurses, and professors looking for luxury short-term furnished accommodations.
NEW HAVEN, Conn. (PRWEB) April 14, 2023
Hyatus Stays recently introduced a ... |
| 29.07.2021 | 9 reasons to feel great when you’re eating avocados | Avocados are loaded with fiber that can help protect your heart, aid digestion, and manage a healthy weight. Jorge Garcia Argazkiak/Getty Images
Avocadoes are a fruit that can help with weight management, and heart, eye, and skin health.
Av... |
| 25.09.2015 | Morning Read: Essure in the crosshairs, meet Martin Shkreli before Daraprim | LIFE SCIENCES
Replimune raised $30 million in a Series A round led by Atlas Venture to develop next-generation oncolytic viruses for cancer. — BioCentury
Intarcia Therapeutics acquired former GlaxoSmithKline’s Phoundry Pharma. – MassDevice
... |
| 12.02.2013 | Study: Higher readmission rates don’t mean fewer deaths | “I feel we’ve dispelled the notion that your performance in mortality will dictate your performance in readmission,” said Dr. Harlan Krumholz of Yale University School of Medicine, the lead author of the study. “This result says they appear... |
| - | Morning Read: Essure in the crosshairs, meet Martin Shkreli before Daraprim | TOP STORIES
An FDA panel took sharp aim at the regulator over not going far enough to test Bayer AG’s permanent contraceptive device Essure. It follows a steady stream of complaints from women who have used the device over chronic pain and ... |
| - | Study: Higher readmission rates don’t mean fewer deaths | Some hospitals with high readmission rates say they’re saving lives by bringing patients back at the first hint of trouble. The evidence for this is that a handful of hospitals with high readmission rates also have extremely low death rates... |